The Division of Translational Cancer Research (TCR) was founded 2013 in conjunction with the formation of Lund University Cancer Center (LUCC) at Medicon Village. TCR consists of nine research groups with different areas of expertise, but together working on projects with the common goal of improving cancer diagnostics and cancer therapy. Our multidisciplinary experimental settings include human genetics, mouse genetics, human tissue platform, stem cell biology and advanced maging, aiming at creating novel diagnostic tools and therapeutic modalities. We believe that the impact of ongoing projects at TCR will open up new horizons and opportunities for individualized treatment of cancer patients, which includes diagnostic tests for matching the right drug to the right patient.